CVE-2026-21974 is a medium severity vulnerability with a CVSS score of 5.3. No known public exploits at this time.
Very low probability of exploitation
EPSS predicts the probability of exploitation in the next 30 days based on real-world threat data, complementing CVSS severity scores with actual risk assessment.
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
Please cite this page when referencing data from Strobes VI. Proper attribution helps support our vulnerability intelligence research.